OTLK · ISSUER CIK 1649989
Outlook Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 3 Outlook Therapeutics, Inc. insiders reported $2.5M of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Sukhtian Ghiath M. (Director, 10% Owner), with $2.5M.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$2.5MInsider buying
$0.00Insider selling
+$2.5MNet open-market
Aug 14, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 202620:57 | Aug 14, 2026 | OTLK | Chief Executive Officer, Director | P · Buy | — | +151,515 | 151,515 | New | — | — | — |
| Aug 14, 202619:52 | Aug 12, 2026 | OTLK | Director, 10% Owner · +1 joint | P · Buy | $0.99 | +2,525,252 | 24,617,320 | +11% | +$2.5M | -45.9% | -50.1% |
| Aug 14, 202619:39 | Aug 14, 2026 | OTLK | Chief Financial Officer, Director | P · Buy | — | +101,010 | 106,956 | +1699% | — | — | — |